EMEA (Europe, Middle East and Africa) Intranasal Drug Delivery Device Market Report 2017

July 2017 | 103 pages | ID: EB09B43CFB5EN
QYResearch

Abstracts

In this report, the EMEA Intranasal Drug Delivery Device market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Intranasal Drug Delivery Device for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Intranasal Drug Delivery Device market competition by top manufacturers/players, with Intranasal Drug Delivery Device sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Teleflex
• OptiNose
• Kurve Technology
• Mystic Pharmaceuticals
• Aptar Group
• Alchemy Pharmatech
• SNBL
• MedInvent

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

• Nasal sprays
• Ointments
• Solutions

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Intranasal Drug Delivery Device for each application, including

• Analgesic
• Allergic infections
• Pain management
• Osteoporosis
• Sexual dysfunction
• Vaccines

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Intranasal Drug Delivery Device Market Report 2017

1 INTRANASAL DRUG DELIVERY DEVICE OVERVIEW

1.1 Product Overview and Scope of Intranasal Drug Delivery Device
1.2 Classification of Intranasal Drug Delivery Device
  1.2.1 EMEA Intranasal Drug Delivery Device Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Intranasal Drug Delivery Device Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Nasal sprays
  1.2.4 Ointments
  1.2.5 Solutions
1.3 EMEA Intranasal Drug Delivery Device Market by Application/End Users
  1.3.1 EMEA Intranasal Drug Delivery Device Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Analgesic
  1.3.3 Allergic infections
  1.3.4 Pain management
  1.3.5 Osteoporosis
  1.3.6 Sexual dysfunction
  1.3.7 Vaccines
1.4 EMEA Intranasal Drug Delivery Device Market by Region
  1.4.1 EMEA Intranasal Drug Delivery Device Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Intranasal Drug Delivery Device (2012-2022)
  1.5.1 EMEA Intranasal Drug Delivery Device Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Intranasal Drug Delivery Device Revenue and Growth Rate (2012-2022)

2 EMEA INTRANASAL DRUG DELIVERY DEVICE COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Intranasal Drug Delivery Device Market Competition by Players/Manufacturers
  2.1.1 EMEA Intranasal Drug Delivery Device Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Intranasal Drug Delivery Device Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Intranasal Drug Delivery Device Sale Price by Players (2012-2017)
2.2 EMEA Intranasal Drug Delivery Device (Volume and Value) by Type/Product Category
  2.2.1 EMEA Intranasal Drug Delivery Device Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Intranasal Drug Delivery Device Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Intranasal Drug Delivery Device Sale Price by Type (2012-2017)
2.3 EMEA Intranasal Drug Delivery Device (Volume) by Application
2.4 EMEA Intranasal Drug Delivery Device (Volume and Value) by Region
  2.4.1 EMEA Intranasal Drug Delivery Device Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Intranasal Drug Delivery Device Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Intranasal Drug Delivery Device Sales Price by Region (2012-2017)

3 EUROPE INTRANASAL DRUG DELIVERY DEVICE (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Intranasal Drug Delivery Device Sales and Value (2012-2017)
  3.1.1 Europe Intranasal Drug Delivery Device Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Intranasal Drug Delivery Device Revenue and Growth Rate (2012-2017)
3.2 Europe Intranasal Drug Delivery Device Sales and Market Share by Type
3.3 Europe Intranasal Drug Delivery Device Sales and Market Share by Application
3.4 Europe Intranasal Drug Delivery Device Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Intranasal Drug Delivery Device Sales Volume by Countries (2012-2017)
  3.4.2 Europe Intranasal Drug Delivery Device Revenue by Countries (2012-2017)
  3.4.3 Germany Intranasal Drug Delivery Device Sales and Growth Rate (2012-2017)
  3.4.4 France Intranasal Drug Delivery Device Sales and Growth Rate (2012-2017)
  3.4.5 UK Intranasal Drug Delivery Device Sales and Growth Rate (2012-2017)
  3.4.6 Russia Intranasal Drug Delivery Device Sales and Growth Rate (2012-2017)
  3.4.7 Italy Intranasal Drug Delivery Device Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Intranasal Drug Delivery Device Sales and Growth Rate (2012-2017)

4 MIDDLE EAST INTRANASAL DRUG DELIVERY DEVICE (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Intranasal Drug Delivery Device Sales and Value (2012-2017)
  4.1.1 Middle East Intranasal Drug Delivery Device Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Intranasal Drug Delivery Device Revenue and Growth Rate (2012-2017)
4.2 Middle East Intranasal Drug Delivery Device Sales and Market Share by Type
4.3 Middle East Intranasal Drug Delivery Device Sales and Market Share by Application
4.4 Middle East Intranasal Drug Delivery Device Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Intranasal Drug Delivery Device Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Intranasal Drug Delivery Device Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Intranasal Drug Delivery Device Sales and Growth Rate (2012-2017)
  4.4.4 Israel Intranasal Drug Delivery Device Sales and Growth Rate (2012-2017)
  4.4.5 UAE Intranasal Drug Delivery Device Sales and Growth Rate (2012-2017)
  4.4.6 Iran Intranasal Drug Delivery Device Sales and Growth Rate (2012-2017)

5 AFRICA INTRANASAL DRUG DELIVERY DEVICE (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Intranasal Drug Delivery Device Sales and Value (2012-2017)
  5.1.1 Africa Intranasal Drug Delivery Device Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Intranasal Drug Delivery Device Revenue and Growth Rate (2012-2017)
5.2 Africa Intranasal Drug Delivery Device Sales and Market Share by Type
5.3 Africa Intranasal Drug Delivery Device Sales and Market Share by Application
5.4 Africa Intranasal Drug Delivery Device Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Intranasal Drug Delivery Device Sales Volume by Countries (2012-2017)
  5.4.2 Africa Intranasal Drug Delivery Device Revenue by Countries (2012-2017)
  5.4.3 South Africa Intranasal Drug Delivery Device Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Intranasal Drug Delivery Device Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Intranasal Drug Delivery Device Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Intranasal Drug Delivery Device Sales and Growth Rate (2012-2017)

6 EMEA INTRANASAL DRUG DELIVERY DEVICE MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Teleflex
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Intranasal Drug Delivery Device Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Teleflex Intranasal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 OptiNose
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Intranasal Drug Delivery Device Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 OptiNose Intranasal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Kurve Technology
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Intranasal Drug Delivery Device Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Kurve Technology Intranasal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Mystic Pharmaceuticals
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Intranasal Drug Delivery Device Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Mystic Pharmaceuticals Intranasal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Aptar Group
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Intranasal Drug Delivery Device Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Aptar Group Intranasal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Alchemy Pharmatech
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Intranasal Drug Delivery Device Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Alchemy Pharmatech Intranasal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 SNBL
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Intranasal Drug Delivery Device Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 SNBL Intranasal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 MedInvent
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Intranasal Drug Delivery Device Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 MedInvent Intranasal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview

7 INTRANASAL DRUG DELIVERY DEVICE MANUFACTURING COST ANALYSIS

7.1 Intranasal Drug Delivery Device Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Intranasal Drug Delivery Device

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Intranasal Drug Delivery Device Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Intranasal Drug Delivery Device Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA INTRANASAL DRUG DELIVERY DEVICE MARKET FORECAST (2017-2022)

11.1 EMEA Intranasal Drug Delivery Device Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Intranasal Drug Delivery Device Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Intranasal Drug Delivery Device Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Intranasal Drug Delivery Device Price and Trend Forecast (2017-2022)
11.2 EMEA Intranasal Drug Delivery Device Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Intranasal Drug Delivery Device Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Intranasal Drug Delivery Device Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Intranasal Drug Delivery Device Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Intranasal Drug Delivery Device Sales Forecast by Type (2017-2022)
11.7 EMEA Intranasal Drug Delivery Device Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Intranasal Drug Delivery Device
Figure EMEA Intranasal Drug Delivery Device Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Intranasal Drug Delivery Device Sales Volume Market Share by Type (Product Category) in 2016
Figure Nasal sprays Product Picture
Figure Ointments Product Picture
Figure Solutions Product Picture
Figure EMEA Intranasal Drug Delivery Device Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Intranasal Drug Delivery Device by Application in 2016
Figure Analgesic Examples
Table Key Downstream Customer in Analgesic
Figure Allergic infections Examples
Table Key Downstream Customer in Allergic infections
Figure Pain management Examples
Table Key Downstream Customer in Pain management
Figure Osteoporosis Examples
Table Key Downstream Customer in Osteoporosis
Figure Sexual dysfunction Examples
Table Key Downstream Customer in Sexual dysfunction
Figure Vaccines Examples
Table Key Downstream Customer in Vaccines
Figure EMEA Intranasal Drug Delivery Device Market Size (Million USD) by Region (2012-2022)
Figure Europe Intranasal Drug Delivery Device Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Intranasal Drug Delivery Device Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Intranasal Drug Delivery Device Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Intranasal Drug Delivery Device Revenue (Million USD) Status and Forecast by Countries
Figure Africa Intranasal Drug Delivery Device Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Intranasal Drug Delivery Device Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Intranasal Drug Delivery Device Sales Volume and Growth Rate (2012-2022)
Figure EMEA Intranasal Drug Delivery Device Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Intranasal Drug Delivery Device Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Intranasal Drug Delivery Device Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Intranasal Drug Delivery Device Sales Share by Players (2012-2017)
Figure 2016 Intranasal Drug Delivery Device Sales Share by Players
Figure 2017 Intranasal Drug Delivery Device Sales Share by Players
Figure EMEA Intranasal Drug Delivery Device Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Intranasal Drug Delivery Device Revenue (Million USD) by Players (2012-2017)
Table EMEA Intranasal Drug Delivery Device Revenue Share by Players (2012-2017)
Table 2016 EMEA Intranasal Drug Delivery Device Revenue Share by Players
Table 2017 EMEA Intranasal Drug Delivery Device Revenue Share by Players
Table EMEA Intranasal Drug Delivery Device Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Intranasal Drug Delivery Device Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Intranasal Drug Delivery Device Sales Share by Type (2012-2017)
Figure Sales Market Share of Intranasal Drug Delivery Device by Type (2012-2017)
Figure EMEA Intranasal Drug Delivery Device Sales Market Share by Type (2012-2017)
Table EMEA Intranasal Drug Delivery Device Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Intranasal Drug Delivery Device Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Intranasal Drug Delivery Device by Type in 2016
Table EMEA Intranasal Drug Delivery Device Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Intranasal Drug Delivery Device Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Intranasal Drug Delivery Device Sales Share by Application (2012-2017)
Figure Sales Market Share of Intranasal Drug Delivery Device by Application (2012-2017)
Figure EMEA Intranasal Drug Delivery Device Sales Market Share by Application in 2016
Table EMEA Intranasal Drug Delivery Device Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Intranasal Drug Delivery Device Sales Share by Region (2012-2017)
Figure Sales Market Share of Intranasal Drug Delivery Device by Region (2012-2017)
Figure EMEA Intranasal Drug Delivery Device Sales Market Share in 2016
Table EMEA Intranasal Drug Delivery Device Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Intranasal Drug Delivery Device Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Intranasal Drug Delivery Device by Region (2012-2017)
Figure EMEA Intranasal Drug Delivery Device Revenue Market Share Regions in 2016
Table EMEA Intranasal Drug Delivery Device Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Intranasal Drug Delivery Device Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Intranasal Drug Delivery Device Revenue and Growth Rate (2012-2017)
Table Europe Intranasal Drug Delivery Device Sales (K Units) by Type (2012-2017)
Table Europe Intranasal Drug Delivery Device Market Share by Type (2012-2017)
Figure Europe Intranasal Drug Delivery Device Market Share by Type in 2016
Table Europe Intranasal Drug Delivery Device Sales (K Units) by Application (2012-2017)
Table Europe Intranasal Drug Delivery Device Market Share by Application (2012-2017)
Figure Europe Intranasal Drug Delivery Device Market Share by Application in 2016
Table Europe Intranasal Drug Delivery Device Sales (K Units) by Countries (2012-2017)
Table Europe Intranasal Drug Delivery Device Sales Market Share by Countries (2012-2017)
Figure Europe Intranasal Drug Delivery Device Sales Market Share by Countries (2012-2017)
Figure Europe Intranasal Drug Delivery Device Sales Market Share by Countries in 2016
Table Europe Intranasal Drug Delivery Device Revenue (Million USD) by Countries (2012-2017)
Table Europe Intranasal Drug Delivery Device Revenue Market Share by Countries (2012-2017)
Figure Europe Intranasal Drug Delivery Device Revenue Market Share by Countries (2012-2017)
Figure Europe Intranasal Drug Delivery Device Revenue Market Share by Countries in 2016
Figure Germany Intranasal Drug Delivery Device Sales (K Units) and Growth Rate (2012-2017)
Figure France Intranasal Drug Delivery Device Sales (K Units) and Growth Rate (2012-2017)
Figure UK Intranasal Drug Delivery Device Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Intranasal Drug Delivery Device Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Intranasal Drug Delivery Device Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Intranasal Drug Delivery Device Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Intranasal Drug Delivery Device Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Intranasal Drug Delivery Device Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Intranasal Drug Delivery Device Sales (K Units) by Type (2012-2017)
Table Middle East Intranasal Drug Delivery Device Market Share by Type (2012-2017)
Figure Middle East Intranasal Drug Delivery Device Market Share by Type (2012-2017)
Table Middle East Intranasal Drug Delivery Device Sales (K Units) by Applications (2012-2017)
Table Middle East Intranasal Drug Delivery Device Market Share by Applications (2012-2017)
Figure Middle East Intranasal Drug Delivery Device Sales Market Share by Application in 2016
Table Middle East Intranasal Drug Delivery Device Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Intranasal Drug Delivery Device Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Intranasal Drug Delivery Device Sales Volume Market Share by Countries in 2016
Table Middle East Intranasal Drug Delivery Device Revenue (Million USD) by Countries (2012-2017)
Table Middle East Intranasal Drug Delivery Device Revenue Market Share by Countries (2012-2017)
Figure Middle East Intranasal Drug Delivery Device Revenue Market Share by Countries (2012-2017)
Figure Middle East Intranasal Drug Delivery Device Revenue Market Share by Countries in 2016
Figure Saudi Arabia Intranasal Drug Delivery Device Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Intranasal Drug Delivery Device Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Intranasal Drug Delivery Device Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Intranasal Drug Delivery Device Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Intranasal Drug Delivery Device Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Intranasal Drug Delivery Device Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Intranasal Drug Delivery Device Sales (K Units) by Type (2012-2017)
Table Africa Intranasal Drug Delivery Device Sales Market Share by Type (2012-2017)
Figure Africa Intranasal Drug Delivery Device Sales Market Share by Type (2012-2017)
Figure Africa Intranasal Drug Delivery Device Sales Market Share by Type in 2016
Table Africa Intranasal Drug Delivery Device Sales (K Units) by Application (2012-2017)
Table Africa Intranasal Drug Delivery Device Sales Market Share by Application (2012-2017)
Figure Africa Intranasal Drug Delivery Device Sales Market Share by Application (2012-2017)
Table Africa Intranasal Drug Delivery Device Sales Volume (K Units) by Countries (2012-2017)
Table Africa Intranasal Drug Delivery Device Sales Market Share by Countries (2012-2017)
Figure Africa Intranasal Drug Delivery Device Sales Market Share by Countries (2012-2017)
Figure Africa Intranasal Drug Delivery Device Sales Market Share by Countries in 2016
Table Africa Intranasal Drug Delivery Device Revenue (Million USD) by Countries (2012-2017)
Table Africa Intranasal Drug Delivery Device Revenue Market Share by Countries (2012-2017)
Figure Africa Intranasal Drug Delivery Device Revenue Market Share by Countries (2012-2017)
Figure Africa Intranasal Drug Delivery Device Revenue Market Share by Countries in 2016
Figure South Africa Intranasal Drug Delivery Device Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Intranasal Drug Delivery Device Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Intranasal Drug Delivery Device Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Intranasal Drug Delivery Device Sales (K Units) and Growth Rate (2012-2017)
Table Teleflex Intranasal Drug Delivery Device Basic Information List
Table Teleflex Intranasal Drug Delivery Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Teleflex Intranasal Drug Delivery Device Sales (K Units) and Growth Rate (2012-2017)
Figure Teleflex Intranasal Drug Delivery Device Sales Market Share in EMEA (2012-2017)
Figure Teleflex Intranasal Drug Delivery Device Revenue Market Share in EMEA (2012-2017)
Table OptiNose Intranasal Drug Delivery Device Basic Information List
Table OptiNose Intranasal Drug Delivery Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure OptiNose Intranasal Drug Delivery Device Sales (K Units) and Growth Rate (2012-2017)
Figure OptiNose Intranasal Drug Delivery Device Sales Market Share in EMEA (2012-2017)
Figure OptiNose Intranasal Drug Delivery Device Revenue Market Share in EMEA (2012-2017)
Table Kurve Technology Intranasal Drug Delivery Device Basic Information List
Table Kurve Technology Intranasal Drug Delivery Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Kurve Technology Intranasal Drug Delivery Device Sales (K Units) and Growth Rate (2012-2017)
Figure Kurve Technology Intranasal Drug Delivery Device Sales Market Share in EMEA (2012-2017)
Figure Kurve Technology Intranasal Drug Delivery Device Revenue Market Share in EMEA (2012-2017)
Table Mystic Pharmaceuticals Intranasal Drug Delivery Device Basic Information List
Table Mystic Pharmaceuticals Intranasal Drug Delivery Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Mystic Pharmaceuticals Intranasal Drug Delivery Device Sales (K Units) and Growth Rate (2012-2017)
Figure Mystic Pharmaceuticals Intranasal Drug Delivery Device Sales Market Share in EMEA (2012-2017)
Figure Mystic Pharmaceuticals Intranasal Drug Delivery Device Revenue Market Share in EMEA (2012-2017)
Table Aptar Group Intranasal Drug Delivery Device Basic Information List
Table Aptar Group Intranasal Drug Delivery Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Aptar Group Intranasal Drug Delivery Device Sales (K Units) and Growth Rate (2012-2017)
Figure Aptar Group Intranasal Drug Delivery Device Sales Market Share in EMEA (2012-2017)
Figure Aptar Group Intranasal Drug Delivery Device Revenue Market Share in EMEA (2012-2017)
Table Alchemy Pharmatech Intranasal Drug Delivery Device Basic Information List
Table Alchemy Pharmatech Intranasal Drug Delivery Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Alchemy Pharmatech Intranasal Drug Delivery Device Sales (K Units) and Growth Rate (2012-2017)
Figure Alchemy Pharmatech Intranasal Drug Delivery Device Sales Market Share in EMEA (2012-2017)
Figure Alchemy Pharmatech Intranasal Drug Delivery Device Revenue Market Share in EMEA (2012-2017)
Table SNBL Intranasal Drug Delivery Device Basic Information List
Table SNBL Intranasal Drug Delivery Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure SNBL Intranasal Drug Delivery Device Sales (K Units) and Growth Rate (2012-2017)
Figure SNBL Intranasal Drug Delivery Device Sales Market Share in EMEA (2012-2017)
Figure SNBL Intranasal Drug Delivery Device Revenue Market Share in EMEA (2012-2017)
Table MedInvent Intranasal Drug Delivery Device Basic Information List
Table MedInvent Intranasal Drug Delivery Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure MedInvent Intranasal Drug Delivery Device Sales (K Units) and Growth Rate (2012-2017)
Figure MedInvent Intranasal Drug Delivery Device Sales Market Share in EMEA (2012-2017)
Figure MedInvent Intranasal Drug Delivery Device Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Intranasal Drug Delivery Device
Figure Manufacturing Process Analysis of Intranasal Drug Delivery Device
Figure Intranasal Drug Delivery Device Industrial Chain Analysis
Table Raw Materials Sources of Intranasal Drug Delivery Device Major Manufacturers in 2016
Table Major Buyers of Intranasal Drug Delivery Device
Table Distributors/Traders List
Figure EMEA Intranasal Drug Delivery Device Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Intranasal Drug Delivery Device Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Intranasal Drug Delivery Device Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Intranasal Drug Delivery Device Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Intranasal Drug Delivery Device Sales Market Share Forecast by Region (2017-2022)
Table EMEA Intranasal Drug Delivery Device Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Intranasal Drug Delivery Device Revenue Market Share Forecast by Region (2017-2022)
Table Europe Intranasal Drug Delivery Device Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Intranasal Drug Delivery Device Sales Market Share Forecast by Countries (2017-2022)
Table Europe Intranasal Drug Delivery Device Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Intranasal Drug Delivery Device Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Intranasal Drug Delivery Device Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Intranasal Drug Delivery Device Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Intranasal Drug Delivery Device Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Intranasal Drug Delivery Device Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Intranasal Drug Delivery Device Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Intranasal Drug Delivery Device Sales Market Share Forecast by Countries (2017-2022)
Table Africa Intranasal Drug Delivery Device Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Intranasal Drug Delivery Device Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Intranasal Drug Delivery Device Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Intranasal Drug Delivery Device Sales Market Share Forecast by Type (2017-2022)
Table EMEA Intranasal Drug Delivery Device Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Intranasal Drug Delivery Device Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources